Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 127

1.

Basal and stimulated calcitonin and procalcitonin by various assays in patients with and without medullary thyroid cancer.

Kratzsch J, Petzold A, Raue F, Reinhardt W, Bröcker-Preuss M, Görges R, Mann K, Karges W, Morgenthaler N, Luster M, Reiners C, Thiery J, Dralle H, Fuhrer D.

Clin Chem. 2011 Mar;57(3):467-74. doi: 10.1373/clinchem.2010.151688. Epub 2010 Dec 15.

2.

Procalcitonin: a marker for the diagnosis and follow-up of patients with medullary thyroid carcinoma.

Algeciras-Schimnich A, Preissner CM, Theobald JP, Finseth MS, Grebe SK.

J Clin Endocrinol Metab. 2009 Mar;94(3):861-8. doi: 10.1210/jc.2008-1862. Epub 2008 Dec 16.

3.

Calcitonin and procalcitonin in patients with medullary thyroid cancer or bacterial infection.

Kaczka K, Mikosiński S, Fendler W, Celnik A, Pomorski L.

Adv Clin Exp Med. 2012 Mar-Apr;21(2):169-78.

4.

Comparison of serum calcitonin and procalcitonin in detecting medullary thyroid carcinoma among patients with thyroid nodules.

Giovanella L, Verburg FA, Imperiali M, Valabrega S, Trimboli P, Ceriani L.

Clin Chem Lab Med. 2013 Jul;51(7):1477-81. doi: 10.1515/cclm-2012-0610.

PMID:
23314540
5.

Prevalence of sporadic medullary thyroid carcinoma: the importance of routine measurement of serum calcitonin in the diagnostic evaluation of thyroid nodules.

Rieu M, Lame MC, Richard A, Lissak B, Sambort B, Vuong-Ngoc P, Berrod JL, Fombeur JP.

Clin Endocrinol (Oxf). 1995 May;42(5):453-60.

PMID:
7621562
6.

Calcitonin screening and pentagastrin testing: predictive value for the diagnosis of medullary carcinoma in nodular thyroid disease.

Herrmann BL, Schmid KW, Goerges R, Kemen M, Mann K.

Eur J Endocrinol. 2010 Jun;162(6):1141-5. doi: 10.1530/EJE-10-0111. Epub 2010 Mar 23.

7.

Calcitonin precursor levels in human medullary thyroid carcinoma.

Bihan H, Becker KL, Snider RH, Nylen E, Vittaz L, Lauret C, Modigliani E, Moretti JL, Cohen R.

Thyroid. 2003 Aug;13(8):819-22.

PMID:
14558925
8.

[Influence of the calcitonin assay on the definition of biochemical cure in patients with medullary thyroid carcinoma].

Hartung-Knemeyer V, Müller S, Nagarajah J, Lahner H, Broecker-Preuss M, Bockisch A, Görges R.

Nuklearmedizin. 2012;51(4):125-32. doi: 10.3413/Nukmed-0454-11-12. Epub 2012 Apr 12. German.

PMID:
22526413
9.

Pentagastrin stimulation test and early diagnosis of medullary thyroid carcinoma using an immunoradiometric assay of calcitonin: comparison with genetic screening in hereditary medullary thyroid carcinoma.

Barbot N, Calmettes C, Schuffenecker I, Saint-André JP, Franc B, Rohmer V, Jallet P, Bigorgne JC.

J Clin Endocrinol Metab. 1994 Jan;78(1):114-20.

PMID:
7904611
10.

Efficacy of procalcitonin measurement in patients after total thyroidectomy due to medullary thyroid carcinoma.

Bolko P, Manuszewska-Jopek E, Michałek K, Waśko R, Jaskuła M, Sowiński J.

Arch Immunol Ther Exp (Warsz). 2003;51(6):415-9.

PMID:
14692663
11.

Value of routine measurement of serum calcitonin concentrations in patients with nodular thyroid disease: A multicenter study.

Papi G, Corsello SM, Cioni K, Pizzini AM, Corrado S, Carapezzi C, Fadda G, Baldini A, Carani C, Pontecorvi A, Roti E.

J Endocrinol Invest. 2006 May;29(5):427-37.

PMID:
16794366
12.

Predictive value of serum calcitonin levels for preoperative diagnosis of medullary thyroid carcinoma in a cohort of 5817 consecutive patients with thyroid nodules.

Costante G, Meringolo D, Durante C, Bianchi D, Nocera M, Tumino S, Crocetti U, Attard M, Maranghi M, Torlontano M, Filetti S.

J Clin Endocrinol Metab. 2007 Feb;92(2):450-5. Epub 2006 Nov 21.

PMID:
17119000
13.

Hypercalcitoninemia in thyroid conditions other than medullary thyroid carcinoma: a comparative analysis of calcium and pentagastrin stimulation of serum calcitonin.

Lorenz K, Elwerr M, Machens A, Abuazab M, Holzhausen HJ, Dralle H.

Langenbecks Arch Surg. 2013 Mar;398(3):403-9. doi: 10.1007/s00423-013-1049-6. Epub 2013 Feb 14.

PMID:
23408061
14.

Predictive value of pentagastrin test for preoperative differential diagnosis between C-cell hyperplasia and medullary thyroid carcinoma in patients with moderately elevated basal calcitonin levels.

Milone F, Ramundo V, Chiofalo MG, Severino R, Paciolla I, Pezzullo L, Lombardi G, Colao A, Faggiano A.

Clin Endocrinol (Oxf). 2010 Jul;73(1):85-8. doi: 10.1111/j.1365-2265.2009.03759.x. Epub 2009 Dec 18.

PMID:
20039894
15.

Basal calcitonin levels and the response to pentagastrin stimulation in patients after kidney transplantation or on chronic hemodialysis as indicators of medullary carcinoma.

Kotzmann H, Schmidt A, Scheuba C, Kaserer K, Watschinger B, Söregi G, Niederle B, Vierhapper H.

Thyroid. 1999 Sep;9(9):943-7.

PMID:
10524574
16.

Is basal ultrasensitive measurement of calcitonin capable of substituting for the pentagastrin-stimulation test?

Pina G, Dubois S, Murat A, Berger N, Niccoli P, Peix JL, Cohen R, Guillausseau C, Charrie A, Chabre O, Cornu C, Borson-Chazot F, Rohmer V; Groupe des Tumeurs Endocrines..

Clin Endocrinol (Oxf). 2013 Mar;78(3):358-64. doi: 10.1111/cen.12001.

PMID:
22913268
17.

Calcitonin concentrations in patients with chronic kidney disease and medullary thyroid carcinoma or c-cell hyperplasia.

Borchhardt KA, Heinzl H, Gessl A, Hörl WH, Kaserer K, Sunder-Plassmann G.

Kidney Int. 2006 Dec;70(11):2014-20. Epub 2006 Oct 18.

18.

Improved diagnostic methods in the follow-up of medullary thyroid carcinoma by highly specific calcitonin measurements.

Engelbach M, Görges R, Forst T, Pfützner A, Dawood R, Heerdt S, Kunt T, Bockisch A, Beyer J.

J Clin Endocrinol Metab. 2000 May;85(5):1890-4.

PMID:
10843170
19.

Routine measurement of serum calcitonin in nodular thyroid diseases allows the preoperative diagnosis of unsuspected sporadic medullary thyroid carcinoma.

Pacini F, Fontanelli M, Fugazzola L, Elisei R, Romei C, Di Coscio G, Miccoli P, Pinchera A.

J Clin Endocrinol Metab. 1994 Apr;78(4):826-9.

PMID:
8157706
20.

Calcitonin measurement to detect medullary thyroid carcinoma in nodular goiter: German evidence-based consensus recommendation.

Karges W, Dralle H, Raue F, Mann K, Reiners C, Grussendorf M, Hüfner M, Niederle B, Brabant G; German Society for Endocrinology (DGE) - Thyroid Section..

Exp Clin Endocrinol Diabetes. 2004 Jan;112(1):52-8.

PMID:
14758572

Supplemental Content

Support Center